Related Experiment Video

Updated: Aug 21, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Role of the BLT2, a leukotriene B4 receptor, in Ras transformation

Min-Hyuk Yoo1, Haiwon Song, Chang-Hoon Woo

  • 1School of Life Sciences and Biotechnology, Korea University, 5-1 Anam-dong, Sungbuk-gu, Seoul 136-701, Korea.

Oncogene
|October 19, 2004
PubMed

Insights

Oncogenic Ras transformation involves the Rac pathway. This study reveals that leukotriene B4 (LTB4) and its receptor BLT2 are key mediators, inhibiting cancer cell growth and tumorigenicity when blocked.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Oncogenic Ras proteins activate multiple signaling pathways, including Rac and Raf-MAPK, driving cell transformation.
  • The downstream effectors of the Rac pathway in Ras-mediated transformation are not fully elucidated.
  • Previous work identified cytosolic phospholipase A2 (cPLA2) and arachidonic acid metabolism as downstream of Rac in Ha-Ras(V12) signaling.

Purpose of the Study:

  • To investigate the role of leukotriene B4 (LTB4) and its receptor BLT2 in Ha-Ras(V12)-induced cell transformation.
  • To determine if blocking the LTB4-BLT2 pathway affects the malignant phenotypes and tumorigenicity of Ras-transformed cells.
  • To assess the expression of BLT2 in human cancers.

Main Methods:

  • Quantification of LTB4, its synthetic enzymes, and BLT2 expression in Ha-Ras(V12)-transformed cells.
  • Pharmacological blockade of BLT2 to assess its impact on cancer cell phenotypes and in vivo tumorigenicity.
  • In situ hybridization to analyze BLT2 expression in human cancer tissues.

Main Results:

  • Leukotriene B4 (LTB4), its synthetic enzymes, and the BLT2 receptor are upregulated in Ha-Ras(V12)-transformed cells.
  • Inhibition of BLT2 significantly suppressed the malignant phenotypes of Ras-transformed cells and their in vivo tumor growth.
  • BLT2 expression was found to be significantly elevated in various human cancers.

Conclusions:

  • The LTB4-BLT2 signaling axis plays a critical role in mediating cell transformation induced by oncogenic Ha-Ras(V12).
  • This pathway likely acts downstream of the Rac-cPLA2 signaling cascade.
  • Targeting the LTB4-BLT2 pathway represents a potential therapeutic strategy for cancers driven by oncogenic Ras.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...